Thailand agrees to manufacture, supply AstraZeneca's experimental COVID-19 vaccine

British Embassy in Bangkok anunced on October 12 that Thailand has agreed to manufacture and supply AstraZeneca Plc's experimental COVID-19 vaccine in souast Asian nation and or neighbouring countries. embassy said that Thai Ministry of Public Health, AstraZeneca, Siam Bioscience and SCG anunced ir intent to manufacture potential COVID-19 vaccine in Thailand. 

“If vaccine is successful, Thailand will receive doses with aim of commencing vaccination of Thai population in first half of 2021,” embassy said in a statement, without specifying number of doses or financial term of deal.

Thailand's Ministry of Public Health said in a separate statement that AstraZeneca is providing potential vaccine at profit and would work with Siam Bioscience to set up manufacturing facilities. AstraZeneca has resumed its Phase 3 trial in UK following a brief pause due to an unexplained illness in a study participant. 

decision to put trial on hold came after leing biopharma companies signed a pledge to continue to make safety and well-being of vaccinated individuals top priority in development of first COVID-19 vaccines. companies include AstraZeneca, BioNTech, GlaxoSmithKline plc, Johnson & Johnson, and Moderna, Inc. among ors.

Re: COVID-19 Vaccine: AstraZeneca Releases Trial Blueprint, Aims For 50% Effectiveness

Re: COVID-19: AstraZeneca Begins Late-st Trials Of Vaccine With 6,000 Participants

Functioning of AZD1222

COVID-19 vaccine candidate, AZD1222, developed by Oxford University and AstraZeneca start producing coronavirus spike protein after it enters cells. spike protein prompts immune system to produce antibodies and trigger T-cells to destroy infected cells. If individual encounters vel coronavirus, antibodies and T-cells are activated to fight virus.

Last month, Australian government signed a $1.7 billion supply and production agreement under which University of Oxford/AstraZeneca and University of Queensland/CSL will provide more than 84.8 million vaccine doses. government struck a deal with CSL Ltd to manufacture two potential coronavirus vaccines - one developed by Oxford University/AstraZeneca and or by CSL’s own labs in collaboration with University of Queensland.

Re: Cana PM Justine Trudeau Anunces $800 Million Deal With AstraZeneca Of COVID-19 Vaccine

Re: Johnson & Johnson Halts COVID-19 Vaccine Trial Due To 'unexplained Illness' In Participant